Remedy Plan Therapeutics
DC - WashingtonBiotechnology
Focus: Remedy Plan Therapeutics is an oncology-focused biotech company specializing in metastasis inhibitors, headquartered in Washington, DC. The company operates with a small active pipeline and maintains marketed radiopharmaceutical assets.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About Remedy Plan Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow Remedy Plan Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
2 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Peak6.2yr
Peak-revenue radiopharmaceutical with 7+ years of exclusivity remaining; provides near-term cash generation.
Help build intelligence for Remedy Plan Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.